We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
-0.05%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+679.66%
AUM
$12.8B
AUM Growth
-$503M
Cap. Flow
-$241M
Cap. Flow %
-1.88%
Top 10 Hldgs %
22.58%
Holding
382
New
39
Increased
93
Reduced
133
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 26.28%
2 Industrials 21.22%
3 Technology 18.95%
4 Consumer Discretionary 13.7%
5 Communication Services 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRC icon
251
California Resources
CRC
$4.77B
$5.33M 0.04%
+130,000
New +$4.25M
HEI.A icon
252
HEICO Corp Class A
HEI.A
$37B
$4.95M 0.04%
41,780
WY icon
253
Weyerhaeuser
WY
$18.2B
$4.93M 0.04%
138,735
AMSC icon
254
American Superconductor
AMSC
$1.5B
$4.88M 0.04%
335,000
+123,000
+58% +$1.7M
NVDA icon
255
NVIDIA
NVDA
$5.27T
$4.58M 0.04%
221,280
-3,120
-1% -$64.8K
LEGN icon
256
Legend Biotech
LEGN
$4B
$4.44M 0.03%
87,821
CERT icon
257
Certara
CERT
$1.23B
$4.38M 0.03%
132,265
-28,648
-18% -$864K
VSEC icon
258
VSE Corp
VSEC
$6.21B
$4.33M 0.03%
90,000
+65,000
+260% +$3.16M
EVI icon
259
EVI Industries
EVI
$181M
$4.09M 0.03%
150,378
FSRX
260
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$3.97M 0.03%
+408,333
New +$3.96M
FWONK icon
261
Liberty Media Series C
FWONK
$25.8B
$3.86M 0.03%
77,709
CCJ icon
262
Cameco
CCJ
$42.4B
$3.8M 0.03%
+175,000
New +$3.31M
TMCI icon
263
Treace Medical Concepts
TMCI
$303M
$3.63M 0.03%
134,866
-430
-0.3% -$11.8K
CSTL icon
264
Castle Biosciences
CSTL
$988M
$3.41M 0.03%
51,233
+389
+0.8% +$27.4K
FNF icon
265
Fidelity National Financial
FNF
$12.9B
$3.34M 0.03%
76,712
KKR icon
266
KKR & Co
KKR
$93.2B
$3.28M 0.03%
53,900
MUSA icon
267
Murphy USA
MUSA
$10.2B
$3.14M 0.02%
18,750
KLRS
268
Kalaris Therapeutics
KLRS
$93.7M
$3.13M 0.02%
5,435
DBRG icon
269
PUT
DigitalBridge
DBRG
$2.95B
$3.02M 0.02%
+125,000
New +$3.45M
CRBU icon
270
Caribou Biosciences
CRBU
$165M
$2.98M 0.02%
+125,000
New +$3.06M
GWW icon
271
W.W. Grainger
GWW
$61.1B
$2.95M 0.02%
7,500
TSIB
272
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
$2.94M 0.02%
+300,000
New +$2.94M
DYN icon
273
Dyne Therapeutics
DYN
$4.95B
$2.74M 0.02%
168,500
JWN
274
DELISTED
Nordstrom
JWN
$2.72M 0.02%
103,000
LEVI icon
275
Levi Strauss
LEVI
$9.09B
$2.66M 0.02%
108,381
+100,000
+1,193% +$2.7M

Similar funds

ArrowMark Colorado Holdings's Q3 2021 Portfolio in Review

As of Q3 2021, ArrowMark Colorado Holdings held 382 positions worth $12.8B, down 3.8% from $13.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

ArrowMark Colorado Holdings's Q3 2021 filing shows 39 new, 93 increased, 133 reduced and 24 closed positions. Its largest new stake was Invivyd: 2,772,927 shares worth $117M. The largest sale was Proofpoint, Inc., an estimated $193M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • ArrowMark Colorado Holdings's largest Q3 2021 buy was Invivyd: 2,772,927 shares worth $117M.
  • ArrowMark Colorado Holdings added most to Purple Innovation in Q3 2021, an estimated $66.2M increase.
  • ArrowMark Colorado Holdings's biggest Q3 2021 reduction was Neurocrine Biosciences, cutting an estimated $54M.
  • ArrowMark Colorado Holdings fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $193M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 23% of its $12.8B portfolio in Q3 2021.
  • ArrowMark Colorado Holdings opened 39 new positions and closed 24 in Q3 2021.
  • ArrowMark Colorado Holdings's portfolio value fell 3.8% quarter-over-quarter to $12.8B.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.